StockData
Oculis Holding AG logo

Oculis Holding AG (OCS) stock

OCSNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as OCSAW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 4, 2026Score 1/30
$7.64+0.14 (+1.87%)

Close on Nov 13, 2026Market cap $459.08MP/E –Yield –

Oculis total assets

Total assets on the balance sheet at the end of each period.

Oculis's total assets was CHF 250.34M at Jun 30, 2026. For fiscal 2025 it was CHF 235.96M, up 96.1% from the year before. The highest annual figure on record is CHF 235.96M in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025CHF 235.96M+96.1%
FY2024Dec 31, 2024CHF 120.35M+5.2%
FY2023Dec 31, 2023CHF 114.35M+208.6%
FY2022Dec 31, 2022CHF 37.06M-36.2%
FY2021Dec 31, 2021CHF 58.04M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026CHF 250.34M+80.4%
Q4 FY2025Dec 31, 2025CHF 235.96M+106.3%
Q2 FY2025Jun 30, 2025CHF 181.62M+390.1%
Q4 FY2024Dec 31, 2024CHF 120.35M+107.4%
Q2 FY2024Jun 30, 2024CHF 138.73M–
Q4 FY2023Dec 31, 2023CHF 114.35M–
Q4 FY2022Dec 31, 2022CHF 37.06M–
Q4 FY2021Dec 31, 2021CHF 58.04M–

More Oculis figures

See a number that looks wrong?